MedPath
NMPA Approval

Mirabegron Sustained-release Tablets

国药准字HJ20171298

March 15, 2022

H20171298

Drug Information

米拉贝隆缓释片

贝坦利

片剂

25mg

化学药品

March 15, 2022

March 14, 2027

Company Information

Applicant Company

Sylviusweg 62,2333 BE Leiden,The Netherlands

Manufacturing Company

avara pharmaceutical technologies inc.

3300 Marshall Avenue,Norman,OK 73072,USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

米拉贝隆缓释片 - NMPA 批准文号 | MedPath